Compare Hewlett Packard Enterprise Co (HPE) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hewlett Packard Enterprise Co vs Moderna, Inc. — how do they compare? Hewlett Packard Enterprise Co trades at $45.44 (market cap $59.01B), while Moderna, Inc. trades at $60.08 (market cap $23.60B). The key difference: Hewlett Packard Enterprise Co is far larger — about 2.5× Moderna, Inc.'s market cap, and Hewlett Packard Enterprise Co pays a 1.28% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| HPE | MRNA | |
|---|---|---|
Market Cap | $59.01B | $23.60B |
Sector | Technology | Health |
52-Week High | $56.14 | $81.80 |
52-Week Low | $19.81 | $22.36 |
Enterprise Value | $74.96B | $19.70B |
Dividend Yield | 1.28% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HPE trades at $44.95, down 1.9% today, with a bearish technical signal despite recent earnings beats. The stock shows strong AI infrastructure momentum with a record $6.3 billion backlog, though 2025 net income declined sharply to $57 million. Valuation metrics include a P/E of 42.8 and P/S of 1.6, while analyst consensus favors a Buy rating with a $69.69 price target representing 55% upside potential.
HPE's transformation into an AI infrastructure leader presents significant growth opportunity, supported by strong enterprise demand and improving cash flow projections. Key risks include competitive pressure in AI hardware, execution challenges with Juniper integration, and volatile cash flow patterns. The current valuation appears reasonable given AI growth prospects despite near-term profitability concerns.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hewlett Packard Enterprise Co
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment.
Read more on HPE →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
